AwardTape · Defense awards · Research and development · Defense systems R&D · HDTRA117C0070
HDTRA117C0070: -$460K definitive contract to Venatorx Pharmaceuticals Inc
Venatorx Pharmaceuticals Inc holds a definitive contract from Defense Threat Reduction Agency with -$460K obligated since Oct 2023 and $14.3M obligated over its life, against a ceiling of $20.0M. Latest action Apr 30, 2026.
Penicillin binding proteins igf::ot::igf
| PIID | HDTRA117C0070 |
|---|---|
| Type | definitive contract |
| Company | Venatorx Pharmaceuticals Inc |
| Agency | Defense Threat Reduction Agency |
| Contracting office | DEFENSE THREAT REDUCTION AGENCY |
| Category | Research and development · Defense systems R&D |
| PSC | AD92 R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) |
| NAICS | 541711 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| Obligated since Oct 2023 | -$460K |
| Total obligated (lifetime) | $14.3M |
| Ceiling (base and all options) | $20.0M |
| Base date | Aug 28, 2017 |
| Latest action | Apr 30, 2026 |
| End date | Oct 27, 2023 |
| Actions since Oct 2023 | 2 |
| Pricing | Cost plus fixed fee |
| Competition | Full and open competition |
| Place of performance | PA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial